MEAGAN HIGGINS: Open Payments
NPI 1740340025 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 16 payments from 11 companies in 2025. Trend: 2023 $1,242 · 2024 $654 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 3 | $68 |
| Merck Sharp & Dohme LLC | 2 | $56 |
| Janssen Biotech, Inc. | 2 | $53 |
| Incyte Corporation | 2 | $47 |
| Genmab U.S., Inc. | 1 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Legend Biotech USA Inc. | 1 | $29 |
| Celgene Corporation | 1 | $24 |
| PFIZER INC. | 1 | $23 |
| SERVIER PHARMACEUTICALS LLC | 1 | $22 |
Products named: CARVYKTI, JAKAFI, Vanflyta, Epkinly, KEYTRUDA, LYNOZYFIC, PREVYMIS, Enhertu.
Industry payments across AZ — which companies pay providers there.
